This study investigated the use of low dose methotrexate (MTX) (5 mg/m2/infusion) for the treatment of graft-versus-host disease (GVHD), after failure of corticosteroids. Twelve patients had refractory acute GVHD, while eight received MTX for severe chronic GVHD and/or the side effects of corticosteroids. Thirteen patients responded to MTX with six complete remissions and little toxicity, suggesting that low dose MTX is beneficial in refractory GVHD and deserves further investigations.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
graft-versus-host disease
8
low dose
8
low-dose methotrexate
4
methotrexate salvage
4
salvage therapy
4
therapy refractory
4
refractory graft-versus-host
4
disease reduced-intensity
4
reduced-intensity conditioning
4
conditioning allogeneic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!